PerkinElmer reports positive momentum in second quarter of 2015

PerkinElmer has announced its financial results for the second quarter of 2015, during which it delivered a revenue total of $563.9 million (360.86 million pounds).

The life sciences company achieved a constant currency adjusted revenue growth rate of eight percent, or an organic revenue increase of four percent. Meanwhile, its adjusted earnings per share figure of $0.60 represented 12 percent growth in constant currency terms.

Though economic uncertainties in various parts of the world remain a potential threat to growth, PerkinElmer intends to drive further growth in the second half of the year through product innovation.

For the full year 2015, the company now forecasts GAAP earnings per share from continuing operations in the range of $2.00 to $2.05.

Robert Friel, chairman and chief executive officer of PerkinElmer, said: "I am pleased with our accomplishments in the quarter and am particularly encouraged by the broad-based strength of our financial performance through the first half of the year."

The firm was named company of the year for 2014 by the Instrument Business Outlook newsletter earlier this year.